"Das im Jahr 1985 gegründete Kardiocentrum Frankfurt an der Klinik Rotes Kreuz, ist eine der größten kardiologischen Praxen in der Rhein-Main-Region. Mit dem Netzwerk unserer vier kardiologischen Praxen in Offenbach, Bad Vilbel, Frankfurt Rossmarkt und unserer Zentrale an der Klinik Rotes Kreuz, sichern wir die durchgängige Versorgung unserer Patienten und leisten einen wichtigen Beitrag zur Notfallversorgung."

During the past decade, Kardiocentrum Frankfurt an der Klinik Rotes Kreuz conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kardiocentrum Frankfurt an der Klinik Rotes Kreuz" #1 sponsor was "MicroPort CRM" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored, "LivaNova" with 1 trials sponsored and "Medtronic BRC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kardiocentrum Frankfurt an der Klinik Rotes Kreuz" #1 collaborator was "Sorin CRM" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kardiocentrum Frankfurt an der Klinik Rotes Kreuz" are "Atrial Fibrillation" (3 trials), "Atrial Arrhythmia" (1 trials), "Cardiac Arrhythmias" (1 trials), "Heart Failure" (1 trials) and "Heart Failure NYHA Class III and Ambulatory IV" (1 trials). Many other conditions were trialed in "Kardiocentrum Frankfurt an der Klinik Rotes Kreuz" in a lesser frequency.

Most popular intervention types in "Kardiocentrum Frankfurt an der Klinik Rotes Kreuz" are "Device" (4 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Amplatzer Cardiac Plug" (1 trials), "Edoxaban" (1 trials), "Ovatio VR 6250 or DR6550" (1 trials), "PARADYM RF SONR" (1 trials) and "Protecta DR-ICD or CRT-D" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kardiocentrum Frankfurt an der Klinik Rotes Kreuz" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Kardiocentrum Frankfurt an der Klinik Rotes Kreuz". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Kardiocentrum Frankfurt an der Klinik Rotes Kreuz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kardiocentrum Frankfurt an der Klinik Rotes Kreuz, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".